Three new treatments for diabetes recommended by NICEBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2980 (Published 25 May 2016) Cite this as: BMJ 2016;353:i2980
- Ingrid Torjesen
The National Institute for Health and Care Excellence (NICE) has published final guidance recommending three drugs—canagliflozin (Invokana), dapagliflozin (Forxiga), and empagliflozin (Jardiance)—as treatment options for adults with type 2 diabetes if metformin, sulfonylurea, or pioglitazone are contraindicated or not tolerated.1
The three drugs could be used …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial